
You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Filters
Status
Categories
- Advertising (8) Apply Advertising filter
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Biologicals (9) Apply Biologicals filter
- Blood and blood components (4) Apply Blood and blood components filter
- Complementary medicines (22) Apply Complementary medicines filter
- Cosmetics (2) Apply Cosmetics filter
- Disinfectants/Sterilants (4) Apply Disinfectants/Sterilants filter
- Import/Export (1) Apply Import/Export filter
- Labelling/Packaging (23) Apply Labelling/Packaging filter
- Legislation (20) Apply Legislation filter
- Listed medicines (2) Apply Listed medicines filter
- Manufacturing (11) Apply Manufacturing filter
- Medical devices safety (1) Apply Medical devices safety filter
- Medical devices/IVDs (48) Apply Medical devices/IVDs filter
- Medicinal cannabis (1) Apply Medicinal cannabis filter
- Medicines (1) Apply Medicines filter
- OTC medicines (31) Apply OTC medicines filter
- Prescription medicines (25) Apply Prescription medicines filter
- Safety of medicines & medical devices (2) Apply Safety of medicines & medical devices filter
- Scheduling (37) Apply Scheduling filter
- Therapeutic Goods Administration (TGA) (6) Apply Therapeutic Goods Administration (TGA) filter
- Therapeutic goods regulation (6) Apply Therapeutic goods regulation filter
Reforms to the regulatory framework for complementary medicines: Assessment pathways
Closed on 28 March 2017
Therapeutic Goods Order No. 93 (Standard for Medicinal Cannabis)
Closed on 16 January 2017
Designation of Australian conformity assessment bodies for medical devices - Implementation
Closed on 11 January 2017
Accelerated assessment of medical devices - Priority Review pathway - Implementation
Closed on 11 January 2017
The regulatory framework for advertising therapeutic goods - November 2016
Closed on 21 December 2016
Consultation on adoption of a European Union guideline in Australia
Closed on 16 December 2016
Guidance on biovigilance responsibilities of sponsors of biologicals
Closed on 16 December 2016
Guidance on risk management plans for medicines and biologicals
Closed on 16 December 2016
Expedited pathways for prescription medicines
Closed on 12 December 2016
Criteria for comparable overseas regulators
Closed on 12 December 2016